“We'll Consider how the commercialization of the substance matches in with our business enterprise model at Adastra in an effort to position ourselves to guidance the need for a secure offer of copyright,” claimed Main government officer Michael Forbes inside a information launch. The corporation told VICE News it wouldn't be commenting further